Pelthos Therapeutics Inc. (PTHS) ROE
- 2026-06-30: ROE 5755.63%.
- 2026-03-31: ROE -344.77%.
- 2025-12-31: ROE -111.41%.
- 2025-09-30: ROE -40.48%.
Complete source-backed roe history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | 5755.63% |
| 2026-03-31 | -344.77% |
| 2025-12-31 | -111.41% |
| 2025-09-30 | -40.48% |
| 2025-06-30 | 139.15% |
| 2025-03-31 | 175.43% |
| 2024-12-31 | 293.11% |
| 2024-09-30 | 705.05% |
| 2024-06-30 | 5323.31% |
| 2024-03-31 | -794.36% |
| 2023-12-31 | 114.52% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -111.41% |
| 2024-12-31 | 293.11% |
| 2023-12-31 | 114.52% |
| 2022-12-31 | 66.33% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |